Can Lumbar Mulligan Mobilization Improve Gait, Balance, and Trunk Position Sense After Stroke?

March 14, 2025 updated by: Mustafa Ertuğrul Yaşa, Gulhane School of Medicine

Effects of Mulligan-Based Lumbar Mobilization on Trunk Position Sense, Balance, and Gait in Stroke Survivors: A Randomized Study

Stroke is a pathology caused by disturbances in the brain's arterial circulation, leading to high morbidity rates. Individuals who experience a stroke often face neurological impairments such as motor, sensory, and cognitive dysfunctions, which negatively impact muscle strength, postural control, sensation, and gait, reducing their independence in daily activities. Balance deficits in stroke patients increase the risk of falls and contribute to a fear of falling. Improving balance control is a key goal in rehabilitation. The importance of the trunk in balance control and rehabilitation is well-established, as it plays a central role in maintaining stability. In individuals with restricted lumbar mobility, weakened trunk muscles and altered muscle activation can lead to a reduction in proprioception, hip strategy, and spinal stabilization, further impairing balance. Combining conventional exercise approaches with other rehabilitation techniques has been shown to yield more effective outcomes. This study aims to investigate the effects of Mulligan-based lumbar spine mobilization on balance, trunk position sense, and gait in individuals with stroke.

Study Overview

Detailed Description

Stroke is a high-morbidity condition caused by a disruption in the brain's arterial circulation, resulting in various neurological impairments, including motor, sensory, and cognitive deficits. These impairments lead to a decrease in the individual's ability to perform daily activities independently, as muscle strength, postural control, sensation, and gait are negatively affected. Stroke patients often face an increased risk of falls due to balance deficits, which can also contribute to a significant fear of falling. Thus, improving balance control is an essential therapeutic goal in stroke rehabilitation.

The trunk plays a pivotal role in balance control, and it should be the primary focus in rehabilitation programs. In individuals with restricted lumbar mobility, weakened trunk muscles or altered muscle activation patterns lead to decreased lumbar proprioception, impaired hip strategy, and reduced spinal stabilization, all of which contribute to balance difficulties. Recent studies suggest that combining conventional rehabilitation techniques with other interventions can provide more effective results.

In stroke rehabilitation, different mobilization techniques are increasingly being used. One such approach is the Mulligan Concept, which is commonly applied in musculoskeletal disorders, particularly in the treatment of knee, ankle, and shoulder problems in stroke patients. However, there has been limited research on the effectiveness of Mulligan-based lumbar spine mobilization in stroke patients. The Mulligan technique, particularly the Sustained Natural Apophyseal Glides (SNAG) technique, may help improve the individual's ability to move the body freely and enhance mobility and function, ultimately increasing confidence and reducing psychological barriers such as the fear of movement.

This study aims to evaluate the effectiveness of Mulligan-based lumbar mobilization in enhancing balance, trunk position sense, and gait in individuals with stroke. By assessing the impacts of this technique, the study seeks to contribute to the development of more effective rehabilitation strategies that can improve functional outcomes and quality of life for stroke patients.

Study Type

Interventional

Enrollment (Estimated)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Ankara, Turkey, 06010
        • Recruiting
        • Ankara Yıldırım Beyazıt University
        • Contact:
        • Contact:
          • Wala'a Al-deges, MSc
          • Phone Number: 05457269342
        • Principal Investigator:
          • Wala'a AlDEGES

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Participants must meet all of the following conditions to be eligible for the study:

    • Diagnosed with stroke by a neurologist.
    • Aged 30 to 65 years.
    • First-ever stroke (single episode).
    • Stroke duration between 6 to 24 months.
    • Score of ≤3 on the Modified Rankin Scale (mRS).
    • Score of ≥24 on the Mini-Mental State Examination (MMSE).

Exclusion Criteria:

  • Participants will be excluded if they meet any of the following conditions:

    • History of musculoskeletal disorders affecting the spine (e.g., cancer, scoliosis, spondylolisthesis, rheumatoid arthritis, ankylosing spondylitis).
    • Previous lumbar spine surgery.
    • Presence of neurological conditions other than stroke (e.g., Parkinson's disease, multiple sclerosis).
    • Severe visual impairment affecting balance or walking.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Study Group
Participants in this group will receive a combination of Mulligan Sustained Natural Apophyseal Glides (SNAGs) and conventional exercises.
Mulligan Sustained Natural Apophyseal Glides (SNAGs) applied to the lumbar spine, combined with conventional rehabilitation exercises (neuromuscular training, stretching, strengthening, and balance exercises).
Other Names:
  • SNAGs technique with conventional rehab
  • Lumbar SNAGs with rehabilitation exercises
  • Mulligan spine mobilization with physical therapy exercises
  • Lumbar mobilization and functional rehabilitation
Active Comparator: Control Group
Participants in this group will receive conventional physiotherapy exercises
Neuromuscular training, stretching, strengthening, balance exercises, and gait training performed without Mulligan mobilization.
Other Names:
  • Conventional Physiotherapy
  • Standard Rehabilitation Exercises
  • Traditional Physiotherapy Treatment
  • Conventional Exercise Program
  • Conventional Physiotherapy with Balance and Strengthening Exercises

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Static Balance Assessment (Mini-BESTest)
Time Frame: Baseline and After 4 Weeks
The Mini Balance Evaluation Systems Test (Mini-BESTest) assesses balance control, including anticipatory postural adjustments, reactive postural control, sensory orientation, and dynamic gait. It consists of 14 items scored from 0 to 28, with higher scores indicating better balance.
Baseline and After 4 Weeks
Static Balance Assessment (ALDA Balance Device)
Time Frame: Baseline and After 4 Weeks
The ALDA Balance Device uses a motion sensor placed at the L3-5 vertebrae to assess postural sway. It records movement data via a wireless system to analyze balance responses.
Baseline and After 4 Weeks
Dynamic Balance Assessment (Trunk Impairment Scale - TIS)
Time Frame: Baseline and After 4 Weeks
The TIS assesses trunk control in stroke patients through three subcomponents: static sitting balance, dynamic sitting balance, and coordination. The scale consists of 17 items, with a total score ranging from 0 to 23, where higher scores indicate better trunk control.
Baseline and After 4 Weeks
Dynamic Balance Assessment (Functional Reach Test - FRT)
Time Frame: Baseline and After 4 Weeks
The Functional Reach Test evaluates balance stability by measuring the maximum distance a participant can reach forward while maintaining a fixed base of support. Three trials are conducted, and the average distance is recorded. A reach distance of 15 cm or less indicates a high fall risk.
Baseline and After 4 Weeks
Gait Performance (Dynamic Gait Index (DGI))
Time Frame: Baseline and After 4 Weeks
Assesses functional mobility and dynamic walking ability under different conditions (e.g., changing speeds, stepping over obstacles).
Baseline and After 4 Weeks
Gait Performance (10-Meter Walk Test)
Time Frame: Baseline and After 4 Weeks
Measures gait speed by recording the time taken to walk 10 meters.
Baseline and After 4 Weeks
Trunk Position Sense (Proprioception) inclinometers test
Time Frame: Baseline and After 4 Weeks
Inclinometers are among the most commonly used methods for measuring trunk position sense and proprioception. the participant will be guided into a 30° lumbar flexion position three times while standing and will be asked to memorize this position. Then, the participant will be instructed to close their eyes and attempt to replicate the same position. After returning to an upright stance, they will be asked to find the 30° flexion position again. This process will be repeated three times, and the results will be recorded.
Baseline and After 4 Weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Fall Risk (Timed Up and Go (TUG) Test)
Time Frame: Baseline and After 4 Weeks
Evaluates functional mobility by measuring the time taken to stand from a chair, walk 3 meters, turn, walk back, and sit down.
Baseline and After 4 Weeks
Cognitive Function (Standardized Mini Mental Test (SMMT))
Time Frame: Baseline and After 4 Weeks
Assesses cognitive status, including memory, attention, and visuospatial abilities.
Baseline and After 4 Weeks
Functional Independence (Barthel Index)
Time Frame: Baseline and After 4 Weeks
Assesses independence in daily living activities such as mobility, self-care, and transfers.
Baseline and After 4 Weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 8, 2024

Primary Completion (Estimated)

May 10, 2025

Study Completion (Estimated)

June 10, 2025

Study Registration Dates

First Submitted

March 14, 2025

First Submitted That Met QC Criteria

March 14, 2025

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

March 14, 2025

Last Verified

March 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Indivudual participant data will be available to the responsible researcher.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Balance Impairments in Stroke Patients

Clinical Trials on Experimental Group (Mulligan Mobilization + Conventional Therapy)

Subscribe